<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Codexis Inc — News on 6ix</title>
<link>https://6ix.com/company/codexis-inc</link>
<description>Latest news and press releases for Codexis Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 29 Apr 2026 13:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/codexis-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo683553c878dffbe2df0e89d4.webp</url>
<title>Codexis Inc</title>
<link>https://6ix.com/company/codexis-inc</link>
</image>
<item>
<title>Codexis to share RNA manufacturing advances at TIDES USA</title>
<link>https://6ix.com/company/codexis-inc/news/codexis-to-share-rna-manufacturing-advances-at-tides-usa</link>
<guid isPermaLink="true">https://6ix.com/company/codexis-inc/news/codexis-to-share-rna-manufacturing-advances-at-tides-usa</guid>
<pubDate>Wed, 29 Apr 2026 13:00:00 GMT</pubDate>
<description>REDWOOD CITY, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS) a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, will present new data on ECO Synthesis® Manufacturing Platform and provide an update on regulatory engagement for its enzymatic platform at TIDES USA, held May 11–14 at the Hynes Convention Center in Boston. As RNAi therapies expand into larger indications, manufacturing scalability, maintaining process control and</description>
</item>
<item>
<title>Codexis to Report First Quarter 2026 Financial Results on May 7</title>
<link>https://6ix.com/company/codexis-inc/news/codexis-to-report-first-quarter-2026-financial-results-on-may-7</link>
<guid isPermaLink="true">https://6ix.com/company/codexis-inc/news/codexis-to-report-first-quarter-2026-financial-results-on-may-7</guid>
<pubDate>Thu, 23 Apr 2026 13:00:00 GMT</pubDate>
<description>REDWOOD CITY, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex therapeutics, today announced that it will report its financial results for the first quarter of 2026 on Thursday, May 7, 2026, following the close of market. Codexis management will host a conference call and webcast at 4:30 pm Eastern Time to discuss the Company’s financial results and provide a business update. Par</description>
</item>
<item>
<title>Codexis Reports Fourth Quarter and Fiscal Year 2025 Financial Results</title>
<link>https://6ix.com/company/codexis-inc/news/codexis-reports-fourth-quarter-and-fiscal-year-2025-financial-results-30</link>
<guid isPermaLink="true">https://6ix.com/company/codexis-inc/news/codexis-reports-fourth-quarter-and-fiscal-year-2025-financial-results-30</guid>
<pubDate>Wed, 11 Mar 2026 04:00:00 GMT</pubDate>
<description>Q4 revenue of $38.9 million, total revenue of $70.4 million for the fiscal year ended December 31, 2025 Ended year with $78.2 million in cash, cash</description>
</item>
<item>
<title>Codexis signs agreement to manufacture 50 g siRNA using its ECO Synthesis® Manufacturing Platform</title>
<link>https://6ix.com/company/codexis-inc/news/codexis-signs-agreement-to-manufacture-50-g-sirna-using-its-eco-synthesisr-manufacturing-platform</link>
<guid isPermaLink="true">https://6ix.com/company/codexis-inc/news/codexis-signs-agreement-to-manufacture-50-g-sirna-using-its-eco-synthesisr-manufacturing-platform</guid>
<pubDate>Wed, 04 Mar 2026 15:05:00 GMT</pubDate>
<description>Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced it has entered into an agreement with an innovator pharmaceutical company to manufacture 50 grams of small interfering RNA (siRNA) using its proprietary ECO Synthesis manufacturing platform to support preclinical development of a therapeutic candidate targeting a cardiovascular indication.</description>
</item>
<item>
<title>Codexis to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 11</title>
<link>https://6ix.com/company/codexis-inc/news/codexis-to-report-fourth-quarter-and-fiscal-year-2025-financial-results-on-march-11</link>
<guid isPermaLink="true">https://6ix.com/company/codexis-inc/news/codexis-to-report-fourth-quarter-and-fiscal-year-2025-financial-results-on-march-11</guid>
<pubDate>Wed, 25 Feb 2026 05:00:00 GMT</pubDate>
<description>REDWOOD CITY, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable</description>
</item>
<item>
<title>Codexis to Participate in TD Cowen 46th Annual Health Care Conference</title>
<link>https://6ix.com/company/codexis-inc/news/codexis-participate-td-cowen-46th-140000772</link>
<guid isPermaLink="true">https://6ix.com/company/codexis-inc/news/codexis-participate-td-cowen-46th-140000772</guid>
<pubDate>Tue, 17 Feb 2026 14:00:00 GMT</pubDate>
<description>REDWOOD CITY, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex therapeutics, today announced the Company will attend the TD Cowen 46th Annual Health Care Conference, being held March 2-4, 2026, in Boston, Massachusetts. Management will participate in a fireside chat on Tuesday, March 3, 2026, at 11:50 am ET. A live webcast of the event will be available in the Investor Relations s</description>
</item>
<item>
<title>Codexis Achieves ISO 9001:2015 Certification</title>
<link>https://6ix.com/company/codexis-inc/news/codexis-achieves-iso-9001-2015-140000235</link>
<guid isPermaLink="true">https://6ix.com/company/codexis-inc/news/codexis-achieves-iso-9001-2015-140000235</guid>
<pubDate>Tue, 10 Feb 2026 14:00:00 GMT</pubDate>
<description>REDWOOD CITY, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Codexis Inc. (Nasdaq: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, announced today that it has earned its ISO 9001:2015 certification. The official certification reflects Codexis’s dedication to delivering manufacturing excellence by applying a high standard of quality assurance throughout all of its processes, including research and development, product manufacturing and testing, d</description>
</item>
<item>
<title>Codexis Expands Reach of the ECO Synthesis® Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics</title>
<link>https://6ix.com/company/codexis-inc/news/codexis-expands-reach-eco-synthesisr-manufacturing-platform-through-signed-evaluation</link>
<guid isPermaLink="true">https://6ix.com/company/codexis-inc/news/codexis-expands-reach-eco-synthesisr-manufacturing-platform-through-signed-evaluation</guid>
<pubDate>Wed, 07 Jan 2026 05:00:00 GMT</pubDate>
<description>REDWOOD CITY, Calif., Jan. 7, 2026 /PRNewswire/ -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable</description>
</item>
<item>
<title>Codexis Announces Signing of Lease for GMP Manufacturing Facility</title>
<link>https://6ix.com/company/codexis-inc/news/codexis-announces-signing-lease-gmp-manufacturing-facility-2025-11-10</link>
<guid isPermaLink="true">https://6ix.com/company/codexis-inc/news/codexis-announces-signing-lease-gmp-manufacturing-facility-2025-11-10</guid>
<pubDate>Mon, 10 Nov 2025 05:00:00 GMT</pubDate>
<description>REDWOOD CITY, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable</description>
</item>
<item>
<title>Codexis Reports Third Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/codexis-inc/news/codexis-reports-third-quarter-2025-financial-results-2025-11-06</link>
<guid isPermaLink="true">https://6ix.com/company/codexis-inc/news/codexis-reports-third-quarter-2025-financial-results-2025-11-06</guid>
<pubDate>Thu, 06 Nov 2025 05:00:00 GMT</pubDate>
<description>Announces signing of $37.8m Supply Assurance Agreement with Merck Organizational changes streamline company and reduce operational expenses Cash runway</description>
</item>
<item>
<title>Codexis and Nitto Denko Avecia Enter Evaluation Agreement to Explore Codexis's ECO Synthesis® Manufacturing Platform for Therapeutic siRNA Manufacturing</title>
<link>https://6ix.com/company/codexis-inc/news/codexis-and-nitto-denko-avecia-enter-evaluation-agreement-explore-codexiss-eco</link>
<guid isPermaLink="true">https://6ix.com/company/codexis-inc/news/codexis-and-nitto-denko-avecia-enter-evaluation-agreement-explore-codexiss-eco</guid>
<pubDate>Wed, 29 Oct 2025 04:00:00 GMT</pubDate>
<description>REDWOOD CITY, Calif., Oct. 29, 2025 /PRNewswire/ -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable</description>
</item>
<item>
<title>Codexis to Report Third Quarter 2025 Financial Results on November 6</title>
<link>https://6ix.com/company/codexis-inc/news/codexis-report-third-quarter-2025-financial-results-november-6-2025-10-23</link>
<guid isPermaLink="true">https://6ix.com/company/codexis-inc/news/codexis-report-third-quarter-2025-financial-results-november-6-2025-10-23</guid>
<pubDate>Thu, 23 Oct 2025 04:00:00 GMT</pubDate>
<description>REDWOOD CITY, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable</description>
</item>
<item>
<title>Codexis to Participate in Cantor Global Healthcare Conference</title>
<link>https://6ix.com/company/codexis-inc/news/codexis-participate-cantor-global-healthcare-conference-2025-08-28</link>
<guid isPermaLink="true">https://6ix.com/company/codexis-inc/news/codexis-participate-cantor-global-healthcare-conference-2025-08-28</guid>
<pubDate>Thu, 28 Aug 2025 04:00:00 GMT</pubDate>
<description>REDWOOD CITY, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable</description>
</item>
<item>
<title>Codexis Reports Second Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/codexis-inc/news/codexis-reports-second-quarter-2025-financial-results-2025-08-13</link>
<guid isPermaLink="true">https://6ix.com/company/codexis-inc/news/codexis-reports-second-quarter-2025-financial-results-2025-08-13</guid>
<pubDate>Wed, 13 Aug 2025 04:00:00 GMT</pubDate>
<description>Announces revenue of $15.3M vs $14.1M analyst consensus estimate Six presentations featured ECO Synthesis® platform at 2025 TIDES USA annual meeting,</description>
</item>
<item>
<title>Switch Bioworks Expands Leadership Team and Moves into New Facility to Accelerate Development of its Microbial Fertilizer Products</title>
<link>https://6ix.com/company/codexis-inc/news/switch-bioworks-expands-leadership-team-and-moves-into-new-facility-to-accelerate-development-of-its-microbial-fertilizer-products</link>
<guid isPermaLink="true">https://6ix.com/company/codexis-inc/news/switch-bioworks-expands-leadership-team-and-moves-into-new-facility-to-accelerate-development-of-its-microbial-fertilizer-products</guid>
<pubDate>Thu, 07 Aug 2025 11:30:00 GMT</pubDate>
<description>Switch Bioworks, a biotechnology company developing low-cost and sustainable fertilizers, announced today the addition of two senior leaders to its executive team and a move into a new, dedicated corporate headquarters and R&D facility in San Carlos, California.</description>
</item>
<item>
<title>Codexis to Report Second Quarter 2025 Financial Results on August 13</title>
<link>https://6ix.com/company/codexis-inc/news/codexis-report-second-quarter-2025-financial-results-august-13-2025-07-30</link>
<guid isPermaLink="true">https://6ix.com/company/codexis-inc/news/codexis-report-second-quarter-2025-financial-results-august-13-2025-07-30</guid>
<pubDate>Wed, 30 Jul 2025 04:00:00 GMT</pubDate>
<description>REDWOOD CITY, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable</description>
</item>
<item>
<title>Codexis’ Landmark Presentations at TIDES USA Highlight Reproducibility and Process Simplification of the ECO Synthesis Platform for Manufacturing siRNA</title>
<link>https://6ix.com/company/codexis-inc/news/codexis-landmark-presentations-tides-usa-highlight-reproducibility-and-process</link>
<guid isPermaLink="true">https://6ix.com/company/codexis-inc/news/codexis-landmark-presentations-tides-usa-highlight-reproducibility-and-process</guid>
<pubDate>Thu, 22 May 2025 04:00:00 GMT</pubDate>
<description>Presentations by leading siRNA CDMOs, Bachem, Nitto Avecia, and ST Pharm, highlight performance and transferability of Codexis double-stranded RNA ligases</description>
</item>
<item>
<title>Codexis to Participate in Jefferies Global Healthcare Conference</title>
<link>https://6ix.com/company/codexis-inc/news/codexis-participate-jefferies-global-healthcare-conference-2025-05-21</link>
<guid isPermaLink="true">https://6ix.com/company/codexis-inc/news/codexis-participate-jefferies-global-healthcare-conference-2025-05-21</guid>
<pubDate>Wed, 21 May 2025 04:00:00 GMT</pubDate>
<description>REDWOOD CITY, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable</description>
</item>
<item>
<title>Codexis Reports First Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/codexis-inc/news/codexis-reports-first-quarter-2025-financial-results-2025-05-14</link>
<guid isPermaLink="true">https://6ix.com/company/codexis-inc/news/codexis-reports-first-quarter-2025-financial-results-2025-05-14</guid>
<pubDate>Wed, 14 May 2025 04:00:00 GMT</pubDate>
<description>Secured first revenue-generating contract for ECO Synthesis™ manufacturing services Company reiterates full-year financial guidance Six presentations to</description>
</item>
<item>
<title>Codexis Announces Six Presentations Featuring the ECO Synthesis Platform at TIDES USA Annual Meeting</title>
<link>https://6ix.com/company/codexis-inc/news/codexis-announces-six-presentations-featuring-eco-synthesis-platform-tides-usa-annual</link>
<guid isPermaLink="true">https://6ix.com/company/codexis-inc/news/codexis-announces-six-presentations-featuring-eco-synthesis-platform-tides-usa-annual</guid>
<pubDate>Wed, 07 May 2025 04:00:00 GMT</pubDate>
<description>Codexis to showcase data that demonstrate the scalability and reproducibility of its enzymatic siRNA manufacturing processes Three CDMO presentations to</description>
</item>
</channel>
</rss>